Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>In this section: FDA removes black box warning from Chantix; approves first biosimilar to Humira; issues warning about hepatitis C drug; and green lights first drug to treat common childhood form of muscular dystrophy.</p>

FDA Actions